PAS
KLRS

Point72 Asia (Singapore)’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Point72 Asia (Singapore)’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,169
Closed -$11.3K – 1266
2024
Q4 		$11.3K Sell
1,169
-147
-11% -$1.42K ﹤0.01% 729
2024
Q3 		$24.5K Sell
1,316
-2,000
-60% -$37.2K ﹤0.01% 797
2024
Q2 		$55.2K Buy
+3,316
New +$55.2K 0.01% 628